EU Guidelines on COVID-19 and clinical trials

 

CCMO News item: Conditions for (re)starting clinical research in healthcare institutions and CRUs aligned

—–

NEN publishes recommendations for reusing single-use medical devices and provides guidance for non-medical face masks (Dutch)

—-

The European Data Protection Board (EDPD) adopted guidelines (document) on the processing of health data for research purposes in the context of the COVID-19 outbreak and guidelines on geolocation and other tracing tools in the context of the COVID-19 outbreak:

—–

New guidance (MDCG 2020-4) on NB audits during COVID-19 quarantine (ec.europa.eu)

—–

Guidance on medical devices, active implantable medical devices and in vitro diagnostic medical devices in the COVID-19 context (ec.europa.eu)

—–

Coronavirus: more space for eHealth (Dutch)(IGJ)

—–

Coronavirus: Free access to European standards for personal protective equipment, medical devices (in-cyprus)

—–

Guidance French Authorities with respect to ongoing clinical trials during the coronavirus pandemic

—–

Guidance on the Management of Clinical Trials during the COVID-19 (Coronavirus) pandemic (updated to version 3 on April 28) (ec.europa.eu)

—–

Coronavirus: impact on medical-scientific research with humans (Dutch)(IGJ)

—–

Coronavirus: impact on conducting clinical research with humans that falls under the WMO (Dutch)(IGJ)

—–

Dutch Central Clinical Research Committee provides guidance (Dutch, English) for your clinical trial following corona: patient safety first, documentation of protocol deviations can follow later (updated on May 26)(CCMO)